HEADSTART-ACS Completes Enrollment Ahead of Schedule, the Largest Heart Attack Detection Study to Date Using HeartBeam Technology
Go back to HEADSTART-ACS Completes Enrollment Ahead of Schedule, the Largest Heart Attack Detection Study to Date Using HeartBeam Technology| BIOTELEMETRY (NASDAQ: BEAT) | Delayed: 0.39 -0.02 (4.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.41 | 52 Week High | $21.68 | |||
| Open | $0.41 | 52 Week Low | $8.74 | |||
| Day High | $0.41 | P/E | N/A | |||
| Day Low | $0.39 | EPS | $-0.46 | |||
| Volume | 385,682 | |||||



